Trasande et al 1 reported that limiting exposure to alleged endocrine disrupting chemicals would reduce the burden of adult diabetes by 13% and save €4.51 billion/year. On review, however, their… Click to show full abstract
Trasande et al 1 reported that limiting exposure to alleged endocrine disrupting chemicals would reduce the burden of adult diabetes by 13% and save €4.51 billion/year. On review, however, their paper fails to meet standards for good practices in scientific reporting—stating the limitations of the underlying data, clearly articulating uncertainties, and presenting competing views or interpretations of data. First, Trasande et al based their analysis on an existing data set derived from an epidemiological study with significant limitations2 that were not fully discussed by the authors. The limitations include: (1) a cross-sectional design; (2) a 50% …
               
Click one of the above tabs to view related content.